Nabsys 2.0, LLC ("Nabsys"), a pioneer in Electronic Genome Mapping (EGM), today announced the publication of a new preprint ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, today announced that it has signed a non-exclusive license agreement with Sai Life Sciences Limited ("Sai Life Sciences"), an integrated ...

When scientists discovered how bacteria protect themselves against viral invaders, called phages, in the early 2000s, little did they know they'd stumbled upon a revolutionary tool researchers could ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the double ...

The clustered regularly interspaced short palindrome repeats (CRISPR) and Crispr-associated protein 9 (CRISPR/Cas9) is now a well-known, revolutionary method to engineer microbial cells. A key ...

Don't read too much into this year's lackluster performance. Near-term catalysts are firming up.

Cas9 is directed to its target within the DNA sequence through the use of the guide RNA. A specific sequence of DNA that is between two and five nucleotides in length must align with the 3’ end of the ...

CRISPR-Cas9 is a gene-editing tool adapted from a bacterial immune system. It works like molecular scissors that can cut and ...

A virus-built molecular weapon targets DNA with a strange gapped code and may reveal how bacteria acquired the foundations of CRISPR immunity.

When scientists discovered how bacteria protect themselves against viral invaders, called phages, in the early 2000s, little did they know they’d stumbled upon a revolutionary tool researchers could ...